Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Combidex faces panel review

This article was originally published in The Gray Sheet

Executive Summary

Advanced Magnetics' iron oxide nanoparticle-based MRI contrast agent will be evaluated by CDER's Oncologic Drug Advisory Committee March 3. The panel presentation will be jointly prepared by Advanced Magnetics and Cytogen, which holds exclusive U.S. licensing and marketing rights to the product. Combidex's user fee goal date is March 30...
UsernamePublicRestriction

Register

MT021557

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel